FRM-0334: Clinical Trials

1 trial of FRM-0334, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow FRM-0334: new trials by email Literature Review of FRM-0334 trials Research Report on FRM-0334

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation
FRM-0334, Placebo - Granulin Mutation
Phase 2UnknownFORUM Pharmaceuticals Inc302014-10-012016-03-23

Conditions studied

Frontotemporal Dementia (1)

Sponsors

FORUM Pharmaceuticals Inc (1)

Countries

Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 34559230

NIH funding

2014 (1)